Nivolumab,Ipilimumab,celecoxib
BMS
['crc,(-ccrcc),(-tbcrc049),(-mccrcc),(-mbcrc)']
fantabulous results with neoadjuvant immunotherapy in crc pts. presented at the #esmo2022 
A dedicated conference for oncology held under the theme "Access. Educate. Collaborate"